Home
Research
A randomized, evaluator-blinded, parallel group, no treatment controlled, multicentre study to evaluate effectiveness and safety of GP0109 for augmentation and correction of retrusion in the chin region

A randomized, evaluator-blinded, parallel group, no treatment controlled, multicentre study to evaluate effectiveness and safety of GP0109 for augmentation and correction of retrusion in the chin region

Vince Bertucci, MD, FRCPC: Bertucci MedSpa
8333 Weston Road, Suite 100
Woodbridge, ON L4L 8E2
Phone: (905) 850-4415
Hours: Monday: 8 a.m.–5 p.m.
Tuesday: 9 a.m.–5 p.m.
Wednesday – Thursday: 8 a.m.–5 p.m.
Friday: 8 a.m.–4 p.m.

Concluded: 2022

Evaluating the effectiveness and safety of GP0109 dermal filler for augmentation and correction of retrusion in the chin region

This study evaluated the effectiveness of GP0109, a dermal filler, versus no-treatment control for augmentation and correction of retrusion in the chin region.